← Leaderboards
Tamara Crockett
Proneurogen, Inc.
$461,979
Attributed
$1,294,656
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $855.3K · FY2019–20$1M$750K$500K$250K$0
'19
'20
Funding mix
By agency
NIH$1,294,656 · 3
By mechanism
R43$1,294,656 · 3
Top collaborators
- Nina Ossanna4 shared
- Meredith Hay2 shared
- Roberta Diaz Brinton1 shared
Most similar at Proneurogen, Inc.
Same institution · by research overlap
- Nina Ossanna$461,979
- Jeremy Riley$749,453
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposFormulationPre-ClinicalS Disease Related DementiaInnovationDementiaCompliance BehaviorTreatment ProtocolsBrainCommercializationDesignAgonistFeasibility StudiesFda ApprovedCytokineBypassEndotheliumElderlyEncephalitisEnrollmentCerebrovascular CirculationAngiotensinsDoseCells
Grant awards (4)
Formulation of a Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular Contributions to Cognitive Impairment$439,355
R43 · FY2020 · AG
Novel formulations of Allopregnanolone to treat Alzheimer's Disease$449,886
R43 · FY2019 · AG
Microneedle Formulation for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease Related Dementia (ADRD) and Vascular Contributions to Cognitive Impairment and Dementia (VCID)$222,855
R43 · FY2019 · AG
Microneedle Formulation for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease Related Dementia (ADRD) and Vascular Contributions to Cognitive Impairment and Dementia (VCID)$182,560
R43 · FY2019 · AG · contact PI